CONFERENCE PROCEEDINGS
Advanced Search
Home > Proceedings > Volume 12611 > Article
Paper
24 March 2023 Advances in treating HIV-1 infections
Chang Xu
Author Affiliations +
Proceedings Volume 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022); 126111T (2023) https://doi.org/10.1117/12.2669621
Event: International Conference on Biological Engineering and Medical Science (ICBioMed2022), 2022, Oxford, United Kingdom
Abstract
The first case of HIV infection had appeared and was diagnosed in the last century, the 1980s. From then on, this virus comes into people's view and gradually catches scientists' attention. This type of virus infects people by targeting the T cells in people's immune system, and it may develop AIDS, which is a deadly disease that has a high fatality rate and has no cures currently. People with AIDS will have an under-functioning immune system that could be easily infected by other lethal pathogens and then cause severe symptoms and irreversible damage to the human body. Existing research from the global shows that a treatment called antiretroviral therapy has a positive effect on controlling HIV infection hence reducing the probability of developing AIDS. However, many problems still have not been solved until now, for example, the development of drug resistance, and the side effects of drugs act on patients, also there are currently no effective medicines that can be used to cure the HIV-1 infection has been discovered. This paper reviews relevant literature and reviews this virus and disease based on the latest consensus globally, to increase the understanding of HIV infection and lay a foundation for future drug research and clinical treatment.
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Citation Download Citation
Chang Xu "Advances in treating HIV-1 infections", Proc. SPIE 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022), 126111T (24 March 2023); https://doi.org/10.1117/12.2669621
ACCESS THE FULL ARTICLE
ORGANIZATIONAL
Sign in with credentials provided by your organization.
INSTITUTIONAL
Select your institution to access the SPIE Digital Library.
SELECT YOUR INSTITUTION
PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
PERSONAL SIGN IN
No SPIE Account? Create one
PURCHASE THIS CONTENT
SUBSCRIBE TO DIGITAL LIBRARY
50 downloads per 1-year subscription
Members: $195
Non-members: $335 ADD TO CART
25 downloads per 1 - year subscription
Members: $145
Non-members: $250 ADD TO CART
PURCHASE SINGLE ARTICLE
Includes PDF, HTML & Video, when available
Members: $17.00
Non-members: $21.00 ADD TO CART
PROCEEDINGS
 5 PAGES
DOWNLOAD PAPER SAVE TO MY LIBRARY
GET CITATION
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Resistance
Diseases and disorders
Proteins
Viruses
Medicine
Pathogens
Tissues
RELATED CONTENT
Subscribe to Digital Library
Receive Erratum Email Alert
Back to Top